Byren, I., Bejon, P., Atkins, B. L., Angus, B., Masters, S., McLardy-Smith,
P., Gundle, R., and Berendt, A.: One hundred and twelve infected
arthroplasties treated with “DAIR” (debridement, antibiotics and implant
retention): antibiotic duration and outcome, J. Antimicrob. Chemother., 63,
1264–1271, https://doi.org/10.1093/jac/dkp107, 2009.
Chaussade, H., Uçkay, I., Vuagnat, A., Druon, J., Gras, G., Rosset, P.,
Lipsky, B. A., and Bernard, L.: Antibiotic therapy duration for prosthetic
joint infections treated by Debridement and Implant Retention (DAIR):
Similar long-term remission for 6 weeks as compared to 12 weeks, Int. J.
Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis., 63, 37–42,
https://doi.org/10.1016/j.ijid.2017.08.002, 2017.
Ciriviri, J., Talevski, D., Nestorovski, Z., Vraniskoski, T., and
Mishevska-Perchinkova, S.: A Two Phase Treatment of an Infected Hip
Endoprosthesis, Pril. Makedon. Akad. Na Nauk. Umet. Oddelenie Za Med. Nauki,
36, 195–202, https://doi.org/10.1515/prilozi-2015-0067, 2015.
ClinicalTrials.gov: ClinicalTrials.gov,
https://clinicaltrials.gov/, last access: 12
September 2021.
Darley, E. S. R., Bannister, G. C., Blom, A. W., Macgowan, A. P., Jacobson,
S. K., and Alfouzan, W.: Role of early intravenous to oral antibiotic switch
therapy in the management of prosthetic hip infection treated with one- or
two-stage replacement, J. Antimicrob. Chemother., 66, 2405–2408,
https://doi.org/10.1093/jac/dkr277, 2011.
El Helou, O. C., Berbari, E. F., Lahr, B. D., Marculescu, C. E., Razonable,
R. R., Steckelberg, J. M., Hanssen, A. D., and Osmon, D. R.: Management of
prosthetic joint infection treated with two-stage exchange: the impact of
antimicrobial therapy duration, Curr. Orthop. Pract., 22, 333–338,
https://doi.org/10.1097/BCO.0b013e318221813a, 2011.
Esposito, S., Leone, S., Bassetti, M., Borrè, S., Leoncini, F., Meani,
E., Venditti, M., Mazzotta, F., and Bone Joint Infections Committee for the
Italian Society of Infectious Tropical Diseases (SIMIT): Italian guidelines
for the diagnosis and infectious disease management of osteomyelitis and
prosthetic joint infections in adults, Infection, 37, 478–496,
https://doi.org/10.1007/s15010-009-8269-2, 2009.
Fillingham, Y. A., Della Valle, C. J., Suleiman, L. I., Springer, B. D.,
Gehrke, T., Bini, S. A., Segreti, J., Chen, A. F., Goswami, K., Tan, T. L.,
Shohat, N., Diaz-Ledezma, C., Schwartz, A. J., and Parvizi, J.: Definition
of Successful Infection Management and Guidelines for Reporting of Outcomes
After Surgical Treatment of Periprosthetic Joint Infection: From the
Workgroup of the Musculoskeletal Infection Society (MSIS), J. Bone Joint
Surg. Am., 101, e69, https://doi.org/10.2106/JBJS.19.00062, 2019.
Haddad, F. S., Ngu, A., and Negus, J. J.: Prosthetic Joint Infections and
Cost Analysis?, in: A Modern Approach to Biofilm-Related Orthopaedic Implant
Infections: Advances in Microbiology, Infectious Diseases and Public Health
Volume 5, edited by: Drago, L., Springer International Publishing, Cham,
93–100, https://doi.org/10.1007/5584_2016_155, 2017.
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., and Altman, D. G.:
Measuring inconsistency in meta-analyses, BMJ, 327, 557–560,
https://doi.org/10.1136/bmj.327.7414.557, 2003.
Hsieh, P.-H., Huang, K.-C., Lee, P.-C., and Lee, M. S.: Two-stage revision
of infected hip arthroplasty using an antibiotic-loaded spacer:
retrospective comparison between short-term and prolonged antibiotic
therapy, J. Antimicrob. Chemother., 64, 392–397,
https://doi.org/10.1093/jac/dkp177, 2009.
Klouche, S., Sariali, E., and Mamoudy, P.: Total hip arthroplasty revision
due to infection: A cost analysis approach, Orthop. Traumatol. Surg. Res.,
96, 124–132, https://doi.org/10.1016/j.otsr.2009.11.004, 2010.
Kurtz, S., Ong, K., Lau, E., Mowat, F., and Halpern, M.: Projections of
Primary and Revision Hip and Knee Arthroplasty in the United States from
2005 to 2030, J. Bone Joint Surg. Am., 89, 780–785, https://doi.org/10.2106/JBJS.F.00222,
2007.
Kurtz, S. M., Lau, E., Schmier, J., Ong, K. L., Zhao, K., and Parvizi, J.:
Infection Burden for Hip and Knee Arthroplasty in the United States, J.
Arthroplasty, 23, 984–991, https://doi.org/10.1016/j.arth.2007.10.017,
2008.
Kurtz, S. M., Lau, E., Watson, H., Schmier, J. K., and Parvizi, J.: Economic
Burden of Periprosthetic Joint Infection in the United States, J.
Arthroplasty, 27, 61–65.e1, https://doi.org/10.1016/j.arth.2012.02.022,
2012.
Laffer, R. R., Graber, P., Ochsner, P. E., and Zimmerli, W.: Outcome of
prosthetic knee-associated infection: evaluation of 40 consecutive episodes
at a single centre, Clin. Microbiol. Infect., 12, 433–439,
https://doi.org/10.1111/j.1469-0691.2006.01378.x, 2006.
Leitner, L., Türk, S., Heidinger, M., Stöckl, B., Posch, F.,
Maurer-Ertl, W., Leithner, A., and Sadoghi, P.: Trends and Economic Impact
of Hip and Knee Arthroplasty in Central Europe: Findings from the Austrian
National Database, Sci. Rep., 8, 4707,
https://doi.org/10.1038/s41598-018-23266-w, 2018.
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P.,
Clarke, M., Devereaux, P. J., Kleijnen, J., and Moher, D.: ThePRISMA statement for reporting systematic reviews and
meta-analyses ofstudies that evaluate healthcare interventions: explanation
and elaboration, BMJ, 339, b2700, https://doi.org/10.1136/bmj.b2700, 2009.
Ma, H.-H., Chou, T.-F. A., Tsai, S.-W., Chen, C.-F., Wu, P.-K., Chen, C.-M.,
and Chen, W.-M.: Is short-course systemic antibiotic therapy using an
antibiotic-loaded cement spacer safe after resection for infected total knee
arthroplasty? A comparative study, J. Formos. Med. Assoc. Taiwan Yi Zhi,
119, 1070–1079, https://doi.org/10.1016/j.jfma.2019.10.001, 2020.
MacDougall, C., Powell, J. P., Johnson, C. K., Edmond, M. B., and Polk, R.
E.: Hospital and community fluoroquinolone use and resistance in
Staphylococcus aureus and
Escherichia coli in 17 US hospitals, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc.
Am., 41, 435–440, https://doi.org/10.1086/432056, 2005.
Manning, L., Metcalf, S., Dymock, M., Robinson, O., Clark, B., Nelson, R.,
Paterson, D. L., Yates, P., Loewenthal, M., and Dewar, D.: Short-versus
standard-course intravenous antibiotics for peri-prosthetic joint infections
managed with debridement and implant retention: a randomised pilot trial
using a desirability of outcome ranking (DOOR) endpoint, Int. J. Antimicrob.
Agents, 60, 106598,
https://doi.org/10.1016/j.ijantimicag.2022.106598, 2022.
Mittal, Y., Fehring, T. K., Hanssen, A., Marculescu, C., Odum, S. M., and
Osmon, D.: Two-stage reimplantation for periprosthetic knee infection
involving resistant organisms, J. Bone Joint Surg. Am., 89, 1227–1231,
https://doi.org/10.2106/JBJS.E.01192, 2007.
Moore, A. J., Blom, A. W., Whitehouse, M. R., and Gooberman-Hill, R.: Deep
prosthetic joint infection: a qualitative study of the impact on patients
and their experiences of revision surgery, BMJ Open, 5, e009495,
https://doi.org/10.1136/bmjopen-2015-009495, 2015.
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W.,
Steckelberg, J. M., Rao, N., Hanssen, A., Wilson, W. R., and Infectious
Diseases Society of America: Diagnosis and management of prosthetic joint
infection: clinical practice guidelines by the Infectious Diseases Society
of America, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 56,
e1–e25, https://doi.org/10.1093/cid/cis803, 2013.
Ottawa Hospital Research Institute: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses,
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp,
last access: 12 September 2021.
Pettigrew, M. M., Kwon, J., Gent, J. F., Kong, Y., Wade, M., Williams, D. J., Creech, C. B., Evans, S., Pan, Q., Walter, E. B., and Martin, J. M.: Comparison of the Respiratory Resistomes
and Microbiota in Children Receiving Short versus Standard Course Treatment
for Community-Acquired Pneumonia, Mbio, 13, e00195-22, https://doi.org/10.1128/mbio.00195-22, 2022.
Polk, R. E., Johnson, C. K., McClish, D., Wenzel, R. P., and Edmond, M. B.:
Predicting hospital rates of fluoroquinolone-resistant Pseudomonas
aeruginosa from fluoroquinolone use in US hospitals and their surrounding
communities, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 39,
497–503, https://doi.org/10.1086/422647, 2004.
Robertsson, O., Bizjajeva, S., Fenstad, A. M., Furnes, O., Lidgren, L.,
Mehnert, F., Odgaard, A., Pedersen, A. B., and Havelin, L. I.: Knee
arthroplasty in Denmark, Norway and Sweden, Acta Orthop., 81, 82–89,
https://doi.org/10.3109/17453671003685442, 2010.
Schindler, M., Bernard, L., Belaieff, W., Gamulin, A., Racloz, G., Emonet,
S., Lew, D., Hoffmeyer, P., and Uçkay, I.: Epidemiology of adverse
events and Clostridium difficile-associated diarrhea during long-term
antibiotic therapy for osteoarticular infections, J. Infect., 67, 433–438,
https://doi.org/10.1016/j.jinf.2013.07.017, 2013.
Schwarzer, G., Carpenter, J. R., and Rücker, G.: Auth. Meta-Analysis
With R | PDF | R (Programming Language) | Command Line
Interface,
https://www.scribd.com/document/394070235/Guido-Schwarzer-James-R-Carpenter-Gerta-Rucker-Auth-Meta-Analysis-With-R,
last access: 12 September 2021.
Sloan, M., Premkumar, A., and Sheth, N. P.: Projected Volume of Primary
Total Joint Arthroplasty in the U.S., 2014 to 2030, J. Bone Joint Surg. Am., 100, 1455–1460,
https://doi.org/10.2106/JBJS.17.01617, 2018.
Société de Pathologie Infectieuse de Langue Française (SPILF),
Collège des Universitaires de Maladies Infectieuses et Tropicales
(CMIT), Groupe de Pathologie Infectieuse Pédiatrique (GPIP),
Société Française d'Anesthésie et de Réanimation (SFAR),
Société Française de Chirurgie Orthopédique et
Traumatologique (SOFCOT), Société Française d'Hygiène
Hospitalière (SFHH), Société Française de Médecine
Nucléaire (SFMN), Société Française de Médecine Physique
et de Réadaptation (SOFMER), Société Française de
Microbiologie (SFM), Société Française de Radiologie (SFR-Rad),
and Société Française de Rhumatologie (SFR-Rhu): Recommendations
for bone and joint prosthetic device infections in clinical practice
(prosthesis, implants, osteosynthesis), Société de Pathologie
Infectieuse de Langue Française, Med. Mal. Infect., 40, 185–211,
https://doi.org/10.1016/j.medmal.2009.12.009, 2010.
Springer, B. D., Cahue, S., Etkin, C. D., Lewallen, D. G., and McGrory, B.
J.: Infection burden in total hip and knee arthroplasties: an
international registry-based perspective, Arthroplasty Today, 3, 137–140, 2017.
Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S.,
Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., and Eldridge, S.
M.: RoB 2: a revised tool for assessing risk of bias in randomised trials,
BMJ, 366, l4898, https://doi.org/10.1136/bmj.l4898, 2019.
Tande, A. J. and Patel, R.: Prosthetic Joint Infection, Clin. Microbiol.
Rev., 27, 302–345, https://doi.org/10.1128/CMR.00111-13, 2014.
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L.
P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., Williams, D.
N., and IDSA: Practice guidelines for outpatient parenteral antimicrobial
therapy, IDSA guidelines, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc.
Am., 38, 1651–1672, https://doi.org/10.1086/420939, 2004.
Valour, F., Karsenty, J., Bouaziz, A., Ader, F., Tod, M., Lustig, S.,
Laurent, F., Ecochard, R., Chidiac, C., and Ferry, T.: Antimicrobial-Related
Severe Adverse Events during Treatment of Bone and Joint Infection Due to
Methicillin-Susceptible Staphylococcus aureus, Antimicrob. Agents Chemother., 58, 746–755,
https://doi.org/10.1128/AAC.02032-13, 2014.
Yen, H.-T., Hsieh, R. W., Huang, C., Hsu, T.-C., Yeh, T., Chen, Y.-C., Chen,
W.-S., and Lee, C.-C.: Short-course versus long-course antibiotics in
prosthetic joint infections: a systematic review and meta-analysis of one
randomized controlled trial plus nine observational studies, J. Antimicrob.
Chemother., 74, 2507–2516, https://doi.org/10.1093/jac/dkz166, 2019.
Zimmerli, W., Trampuz, A., and Ochsner, P. E.: Prosthetic-Joint Infections,
N. Engl. J. Med., 351, 1645–1654, https://doi.org/10.1056/NEJMra040181,
2004.
